ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 682

Effects Of Extracoporeal Shock Wave Therapy To The Digital Ulcers Of Scleroderma:a Pilot Study

Shinichiro Saito1, Yukiko Kamogawa2, Kyohei Nakamura3, Ryu Watanabe3, Tsuyoshi Shirai2, Yoko Fujita4, Hiroshi Fujii3, Yuko Shirota5, Tomonori Ishii3, Hideo Harigae3, Katsuko Kikuchi6 and Yasushi Kawaguchi7, 1Department of hematology and rheumatology, Tohoku University, Sendai, Japan, 2Tohoku University, Sendai, Japan, 3Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, 4Department of Hematolgy and rheumatolgy, Tohoku University, Sendai, Japan, 5Department of Hematology and Rheumatolgy, Tohoku University, Sendai, Japan, 6Department of Dermatology, Tohoku University, Sendai, Japan, 7Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Extracorporeal shockwave therapy, Raynaud's phenomenon, Scleroderma, skin and ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Vasculopathy, immunological abnormalities and excessive tissue fibrosis are key elements in the pathogenesis of Scleroderma (SSc). In winter,  patients often display Raynaud syndrome, which sometimes causes digital skin ulcers. As these ulcers do not depend on autoimmune or abnormal coagulation, conventional immunosuppressive therapies and anticoagulants are often ineffective. Extracorporeal shock waves (ESW) have been induced primarily in urology for lithotripsy, as its low energy application has yielded evidence for the successful treatment of myocardial ischemia and skin ulcers caused by diabetes. The rationale of this effectiveness is that, new angiogenesis induced by VEGF produced at arteries in the applied area. We tried to introduce ESWT to skin with Raynaud and digital ulcers of SSc.

Methods: We enrolled 9 SSc patients with newly observed digital ulcers: 8 females and 1 male. All 9 patients had been treated with currently available anti-coagulant therapies, especially 6 patients had received intravenous administration of prostaglandin E1. One ESW therapies (ESWT) sitting consisted of 100 impulses at 0.08~0.25 mJ/mm2 per area, 20 areas in both hands and 15 in both feet, totaling 7000 impulses. Sitting were done once a week for 9 weeks. We examined the patients, counting the number of skin ulcers, and checking the Rodnan Skin Score (RSS) as well as patient disability index (HAQ, EQ-5D), pain VAS and objective pain index using PainVisionTM, before and after ESWT. Additionally, the surface skin temperature of all fingers was measured by thermography.

Results: Numbers of skin ulcers were reduced from 5.4 per person to 1.1 by the last treatment of ESWT. Totally, 18 large ulcers (>5mm) were observed from 9 patients before ESWT, 10 disappeared and average size was diminished from 10.8mm into 3.7mm after ESWT. Average HAQ score of 9 patients was improved from 0.57 to 0.43 and other index as EQ5D and PainVisionTM scores also showed improvement. Fingers with the lowest temperatures displayed a rise in temperature. This treatment was minimally invasive and could be repeated without any side effects.

Conclusion: ESWT may be a safe and efficacious treatment that can be used as a type of therapy for indolent digital ulcers caused by SSc.

s

 


Disclosure:

S. Saito,
None;

Y. Kamogawa,
None;

K. Nakamura,
None;

R. Watanabe,
None;

T. Shirai,
None;

Y. Fujita,
None;

H. Fujii,
None;

Y. Shirota,
None;

T. Ishii,
None;

H. Harigae,
None;

K. Kikuchi,
None;

Y. Kawaguchi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-extracoporeal-shock-wave-therapy-to-the-digital-ulcers-of-sclerodermaa-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology